Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges (Q88884604)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29807782%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

title

Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29807782%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

main subject

mesenchymal stem cell

1 reference

inferred from title

cardiovascular disease

1 reference

Luiza Bagno

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29807782%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Konstantinos E Hatzistergos

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29807782%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Wayne Balkan

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29807782%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Joshua M Hare

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29807782%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

publication date

25 May 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29807782%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29807782%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29807782%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29807782%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

page(s)

1610-1623

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29807782%20AND%20SRC:MED&resulttype=core&format=json

Skeletal muscle cells expressing VEGF induce capillary formation and reduce cardiac injury in rats.

28 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Adenoviral PR39 improves blood flow and myocardial function in a pig model of chronic myocardial ischemia by enhancing collateral formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Long-term effects of AAV1/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Inhibition of miR-25 improves cardiac contractility in the failing heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

IRF3 and type I interferons fuel a fatal response to myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Functional screening identifies miRNAs inducing cardiac regeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Multiplex genome engineering using CRISPR/Cas systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Postnatal Cardiac Gene-Editing Using CRISPR/Cas9 with AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Correction of a pathogenic gene mutation in human embryos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Safety and Efficacy of Autologous Skeletal Myoblast Sheets (TCD-51073) for the Treatment of Severe Chronic Heart Failure Due to Ischemic Heart Disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report: Figure 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Comparison of Human Embryonic Stem Cell-Derived Cardiomyocytes, Cardiovascular Progenitors, and Bone Marrow Mononuclear Cells for Cardiac Repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Lineage Reprogramming of Fibroblasts into Proliferative Induced Cardiac Progenitor Cells by Defined Factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Teratocarcinomas Arising from Allogeneic Induced Pluripotent Stem Cell-Derived Cardiac Tissue Constructs Provoked Host Immune Rejection in Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Cardiomyocyte Regeneration: A Consensus Statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Encapsulating Bioactive Hydrogels Improve Rat Heart Function Post Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Stimulatory Effects of Mesenchymal Stem Cells on cKit+ Cardiac Stem Cells Are Mediated by SDF1/CXCR4 and SCF/cKit Signaling Pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Microfluidic Single-Cell Analysis of Transplanted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes After Acute Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Pim1 Kinase Overexpression Enhances ckit+ Cardiac Stem Cell Cardiac Repair Following Myocardial Infarction in Swine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Can mesenchymal stem cells induce tolerance to cotransplanted human embryonic stem cells?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Functional Coupling with Cardiac Muscle Promotes Maturation of hPSC-Derived Sympathetic Neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Mesenchymal stem cells and their conditioned medium improve integration of purified induced pluripotent stem cell-derived cardiomyocyte clusters into myocardial tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Susceptibility of murine induced pluripotent stem cell-derived cardiomyocytes to hypoxia and nutrient deprivation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Concurrent Isolation of 3 Distinct Cardiac Stem Cell Populations From a Single Human Heart Biopsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Adult cardiac-resident MSC-like stem cells with a proepicardial origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Myocardial Reparative Properties of Cardiac Mesenchymal Cells Isolated on the Basis of Adherence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Multilineage potential of adult human mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Potency testing of mesenchymal stromal cell growth expanded in human platelet lysate from different human tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Characterization of human amniotic fluid stem cells and their pluripotential capability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Human Amniotic Fluid Mesenchymal Stem Cells from Second- and Third-Trimester Amniocentesis: Differentiation Potential, Molecular Signature, and Proteome Analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Mesenchymal precursor cells in the blood of normal individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Identification and purification of mesodermal progenitor cells from human adult bone marrow.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Cardiac Cell Therapy 3.0: The Beginning of the End or the End of the Beginning?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Insensitivity of Human iPS Cells-Derived Mesenchymal Stem Cells to Interferon-γ-induced HLA Expression Potentiates Repair Efficiency of Hind Limb Ischemia in Immune Humanized NOD Scid Gamma Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Derivation of mesenchymal stromal cells from pluripotent stem cells through a neural crest lineage using small molecule compounds with defined media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Cardiomyocytes can be generated from marrow stromal cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

In vivo imaging to monitor differentiation and therapeutic effects of transplanted mesenchymal stem cells in myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Effect of aging on human mesenchymal stem cell therapy in ischemic cardiomyopathy patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal S

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

C3orf58, a novel paracrine protein, stimulates cardiomyocyte cell-cycle progression through the PI3K-AKT-CDK7 pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Autologous mesenchymal stem cells mobilize cKit+ and CD133+ bone marrow progenitor cells and improve regional function in hibernating myocardium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Ultrastructural and immunocytochemical analysis of multilineage differentiated human dental pulp- and umbilical cord-derived mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Gene and protein expression analysis of mesenchymal stem cells derived from rat adipose tissue and bone marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Proangiogenic compositions of microvesicles derived from human umbilical cord mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

S-nitrosoglutathione reductase (GSNOR) enhances vasculogenesis by mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Molecular mechanisms and clinical applications of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Comprehensive transcriptomic and proteomic characterization of human mesenchymal stem cells reveals source specific cellular markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Substrate and strain alter the muscle-derived mesenchymal stem cell secretome to promote myogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Implication of the satellite cell in dystrophic muscle fibrosis: a self-perpetuating mechanism of collagen overproduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Activation of host tissue trophic factors through JAK-STAT3 signaling: a mechanism of mesenchymal stem cell-mediated cardiac repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Mesenchymal stem cells: a new strategy for immunosuppression?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

In Vivo Functional Selection Identifies Cardiotrophin-1 as a Cardiac Engraftment Factor for Mesenchymal Stromal Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Safety and efficacy of ixmyelocel-T: an expanded, autologous multi-cellular therapy, in dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

The ixCELL-DCM Trial: Rationale and Design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Exosomes for Intramyocardial Intercellular Communication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

iPSC-MSCs with High Intrinsic MIRO1 and Sensitivity to TNF-α Yield Efficacious Mitochondrial Transfer to Rescue Anthracycline-Induced Cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Lack of Remuscularization Following Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitor Cells in Infarcted Nonhuman Primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Experimental and Computational Insight Into Human Mesenchymal Stem Cell Paracrine Signaling and Heterocellular Coupling Effects on Cardiac Contractility and Arrhythmogenicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Effects of Oxidative Stress on Mesenchymal Stem Cell Biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

A Proinflammatory Secretome Mediates the Impaired Immunopotency of Human Mesenchymal Stromal Cells in Elderly Patients with Atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Senescence in Human Mesenchymal Stem Cells: Functional Changes and Implications in Stem Cell-Based Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

SIRT3 Enhances Mesenchymal Stem Cell Longevity and Differentiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

What's new in cardiac cell therapy? Allogeneic bone marrow stromal cells as "universal donor cells".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Adult bone marrow stem cells regenerate myocardium in ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Autologous stem cell transplantation for myocardial repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Human Umbilical Cord-Derived Mesenchymal Stromal Cells Improve Left Ventricular Function, Perfusion, and Remodeling in a Porcine Model of Chronic Myocardial Ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Allogenic adipose-derived stem cell therapy overcomes ischemia-induced microvessel rarefaction in the myocardium: systems biology study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Intracoronary and retrograde coronary venous myocardial delivery of adipose-derived stem cells in swine infarction lead to transient myocardial trapping with predominant pulmonary redistribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Effects of Intracoronary Administration of Autologous Adipose Tissue-Derived Stem Cells on Acute Myocardial Infarction in a Porcine Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

In vivo myocardial distribution of multipotent progenitor cells following intracoronary delivery in a swine model of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Bone Marrow Mesenchymal Stem Cells (BM-MSCs) Improve Heart Function in Swine Myocardial Infarction Model through Paracrine Effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Cardiac Stem Cell Hybrids Enhance Myocardial Repair.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Transplantation of microencapsulated Schwann cells and mesenchymal stem cells augment angiogenesis and improve heart function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Enhancing efficacy of stem cell transplantation to the heart with a PEGylated fibrin biomatrix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Regulatory T cells enhance mesenchymal stem cell survival and proliferation following autologous cotransplantation in ischemic myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Repairing chronic myocardial infarction with autologous mesenchymal stem cells engineered tissue in rat promotes angiogenesis and limits ventricular remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Bioengineered cardiac patch constructed from multilayered mesenchymal stem cells for myocardial repair.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Composite scaffold provides a cell delivery platform for cardiovascular repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Elastomeric core/shell nanofibrous cardiac patch as a biomimetic support for infarcted porcine myocardium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Enhanced recovery of mechanical function in the canine heart by seeding an extracellular matrix patch with mesenchymal stem cells committed to a cardiac lineage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Tissue Engineering Strategies for Myocardial Regeneration: Acellular Versus Cellular Scaffolds?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Route of Delivery Modulates the Efficacy of Mesenchymal Stem Cell Therapy for Myocardial Infarction: A Meta-Analysis of Preclinical Studies and Clinical Trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Cryopreserved Off-the-Shelf Allogeneic Adipose-Derived Stromal Cells for Therapy in Patients with Ischemic Heart Disease and Heart Failure-A Safety Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Adipose-Derived Stromal Cells for Treatment of Patients with Chronic Ischemic Heart Disease (MyStromalCell Trial): A Randomized Placebo-Controlled Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Intracoronary allogeneic cardiosphere-derived stem cells are safe for use in dogs with dilated cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Rationale and Design of a Clinical Trial to Evaluate the Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction: The Randomized Multicenter D

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Immunogenicity of induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Gene therapy for the treatment of heart failure: promise postponed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Paracrine Effects of the Pluripotent Stem Cell-Derived Cardiac Myocytes Salvage the Injured Myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Protein Phosphatase Inhibitor-1 Gene Therapy in a Swine Model of Nonischemic Heart Failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

AAV9.I-1c delivered via direct coronary infusion in a porcine model of heart failure improves contractility and mitigates adverse remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Cardiac tumorigenic potential of induced pluripotent stem cells in an immunocompetent host with myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Brief Report: External Beam Radiation Therapy for the Treatment of Human Pluripotent Stem Cell-Derived Teratomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Comparison of Magnetic Resonance Imaging and Serum Biomarkers for Detection of Human Pluripotent Stem Cell-Derived Teratomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Cardiovascular Gene Therapy: Past, Present, and Future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2018.05.009

[Autologus bone marrow-derived mesenchymal stem cells intracoronary delivery after acute myocardial infarction in miniature pig]

7 January 2021

1 reference

12 December 2020

The biological characteristics of human third trimester amniotic fluid stem cells.

1 reference

12 December 2020

Fabrication of cardiac patch with decellularized porcine myocardial scaffold and bone marrow mononuclear cells

1 reference

12 December 2020

Miro1 regulates intercellular mitochondrial transport & enhances mesenchymal stem cell rescue efficacy

1 reference

12 December 2020

Pretreatment of Cardiac Stem Cells With Exosomes Derived From Mesenchymal Stem Cells Enhances Myocardial Repair

1 reference

12 December 2020

Growth suppression effect of human mesenchymal stem cells from bone marrow, adipose tissue, and Wharton's jelly of umbilical cord on PBMCs

1 reference

12 December 2020

Comparative Analyses of Immunosuppressive Characteristics of Bone-Marrow, Wharton's Jelly, and Adipose Tissue-Derived Human Mesenchymal Stem Cells

1 reference

12 December 2020

Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction.

1 reference

12 December 2020

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells.

1 reference

12 December 2020

10.1016/J.YMTHE.2018.05.009

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29807782%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29807782%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

PubMed publication ID

29807782

1 reference